Why Ophthalmology Needs a Broader Clinical View

At “Ophthalmic Synergy: Vision in the Context of Health” expert masterclass, held at Favor Park Hotel in Kyiv on February 28, our team joined a discussion centered on one of the most important shifts in modern eye care - the move toward a multidisciplinary approach to diagnosing and treating ophthalmic diseases.

What stayed with us most was this: today, ophthalmology is no longer only about ophthalmology. Meaningful progress increasingly depends on stronger clinical dialogue between ophthalmologists and other specialists - including gynecologists, allergologists, psychiatrists, and clinical pharmacologists. That wider exchange of expertise helps doctors assess patients more comprehensively, sharpen diagnosis, and make better treatment decisions. This multidisciplinary focus was at the core of the event’s agenda.

One of the clearest examples is dry eye disease. For our team, the key takeaway was that this is no longer a narrow or secondary topic. With screen time continuing to rise, alongside stress, blackouts, and the pressures of everyday life, the burden of dry eye is growing rapidly - including among children. That makes awareness, timely attention to symptoms, and everyday eye comfort increasingly important.

Another important signal from the event was highly relevant for pharmaceutical companies working in ophthalmology: scientific and practical content becomes far more valuable when it reflects the real complexity of patient care and the intersection between ophthalmology and other specialties.

And for doctors, perhaps the most practical conclusion is also the most immediate one: widening the clinical frame can improve care starting tomorrow. A broader view of the patient, deeper understanding of comorbidities, and thoughtful use of additional diagnostic methods all contribute to more accurate diagnosis and better treatment choices.

Thank you to the organizers and speakers for a program that placed ophthalmology in a broader clinical context - from dry eye disease and ocular surface disorders to glaucoma, stress, mental health, and systemic factors influencing outcomes.